REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 1st, 2015 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture
This Registration Rights Agreement (this “Agreement”) is made and entered into as of August 31, 2015, between Cesca Therapeutics, Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
SERIES B COMMON STOCK PURCHASE WARRANT CESCA THERAPEUTICS, INC.Cesca Therapeutics Inc. • September 1st, 2015 • Laboratory apparatus & furniture
THIS SERIES B COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the earlier of (x) the date Shareholder Approval is received and effective or (y) February 29, 2016 (the “Initial Exercise Date”) and on or prior to the close of business on February 29, 2017 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Cesca Therapeutics, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock; provided, however, as of the First Closing Date, only up to ______ Warrant Shares (as subject to adjustment hereunder) may be issued on exercise(s) of this Warrant, and the exercisability of the ______ additional Warrant Shares (as subject to adjustment hereunder) shall vest ratably from t
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 1st, 2015 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of August 31, 2015, between Cesca Therapeutics Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITY AGREEMENTSecurity Agreement • September 1st, 2015 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture • New York
This SECURITY AGREEMENT, dated as of August 31, 2015 (this “Agreement”), is among Cesca Therapeutics Inc., a Delaware corporation (the “Company” and, collectively with any Subsidiary of the Company that executes this Agreement including, including, without limitation, by delivery of an Additional Debtor Joinder in substantially the form of Annex A attached hereto, the “Debtors”) and the holders of the Company’s Senior Secured Convertible Debentures due thirty (30) years following their issuance, in the original aggregate principal amount of up to $15,000,000 (collectively, the “Debentures”) signatory hereto, their endorsees, transferees and assigns (collectively, the “Secured Parties”).
SENIOR SECURED CONVERTIBLE DEBENTURE DUE AUGUST 31, 2045Cesca Therapeutics Inc. • September 1st, 2015 • Laboratory apparatus & furniture • New York
THIS SENIOR SECURED CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued Senior Secured Convertible Debentures of Cesca Therapeutics Inc., a Delaware corporation (the “Company”), having its principal place of business at 2711 Citrus Road, Rancho Cordova, California 95742, designated as its Senior Secured Convertible Debenture due August 31, 2045 (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).
